Results 11 to 20 of about 80,519 (274)
JAMA: The Journal of the American Medical Association, 1906 n ...
C. EUGENE RIGGS
openalex +3 more sources
Nature Reviews Disease Primers, 2019 Myasthenia gravis (MG) is an autoimmune disease caused by antibodies against the acetylcholine receptor (AChR), muscle-specific kinase (MuSK) or other AChR-related proteins in the postsynaptic muscle membrane. Localized or general muscle weakness is the predominant symptom and is induced by the antibodies. Patients are grouped according to the presence
Gilhus, Nils Erik +5 more
+9 more sources
Orphanet Journal of Rare Diseases, 2007 Myasthenia gravis (MG) is a rare, autoimmune neuromuscular junction disorder. Contemporary prevalence rates approach 1/5,000. MG presents with painless, fluctuating, fatigable weakness involving specific muscle groups. Ocular weakness with asymmetric ptosis and binocular diplopia is the most typical initial presentation, while early or isolated ...
Juel, Vern C, Massey, Janice M
openaire +3 more sources
Journal of Cardiothoracic Surgery, 2020 Background Despite the burgeoning literature describing preoperative and postoperative risks of a myasthenic crisis after thymectomy (MCAT) in patients with myasthenia gravis, substantial differences exist in the risk factors identified by previous ...
Chaoying Liu +4 more
doaj +1 more source
Neurology and Therapy, 2023 Introduction Myasthenia gravis (MG) is a devastating acquired autoimmune disease that can seriously affect the patient’s quality of life. It is also a common complication of thymoma.
Hongxia Yang +5 more
doaj +1 more source
BMC Medicine, 2021 Background Myasthenia gravis (MG) is an acquired immune-mediated disorder of the neuromuscular junction that causes fluctuating skeletal muscle weakness and fatigue. Pediatric MG and adult MG have many different characteristics, and current MG diagnostic
Peng Liu +10 more
doaj +1 more source
Flow cytofluorimetric analysis of anti-LRP4 (LDL receptor-related protein 4) autoantibodies in Italian patients with Myasthenia gravis [PDF]
, 2015 Background: Myasthenia gravis (MG) is an autoimmune disease in which 90% of patients have autoanti-bodies against the muscle nicotinic acetylcholine receptor (AChR), while autoantibodies to muscle-specific tyrosine kinase (MuSK) have been detected in ...
Antonini, Giovanni +11 more
core +6 more sources
Is chest tube drainage necessary after subxiphoid thoracoscopic thymectomy?
Journal of Cardiothoracic Surgery, 2020 Background Subxiphoid thoracoscopic thymectomy has been increasingly performed in recent years. This study aimed to assess the differences in outcomes between subxiphoid thoracoscopic thymectomy with and without chest tube drainage.
Jiaduo Li +3 more
doaj +1 more source
Frontiers in Pediatrics, 2022 Myasthenia gravis is an organ-specific autoimmune disease. Currently there is no universal guidelines for childhood-onset myasthenia gravis, therefore, treatment strategies are usually based on the guidelines from adult myasthenia gravis patients.
Lifen Yang +6 more
doaj +1 more source
Comparison of the Quantitative Myasthenia Gravis and Myasthenia Gravis Activity of Daily Living Scores From a Clinical Practice Perspective. [PDF]
Muscle NerveABSTRACT Introduction/Aims Myasthenia gravis (MG) is characterized by fluctuating symptoms, making the assessment of disease activity challenging. Discordance between the clinician‐reported quantitative myasthenia gravis (QMG) score and the patient‐reported MG activity of daily living (MG‐ADL) has previously been observed.
Wu W, Petersson M, Piehl F, Brauner S.
europepmc +2 more sources